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Mutant Human Presenilin 1 Protects presenilin 1
Null Mouse against Embryonic Lethality
and Elevates Ab1±42/43 Expression
protein processing and transport (Kovacs et al., 1996;
Lee et al., 1996).
Human PS1 shares 48% amino acid sequence identity
with sel-12 of C. elegans, an essential component of the
Notch/lin-12 signaling pathway, and can rescue the egg-
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laying defects associated with the lossof sel-12 functionMerck Research Laboratories
in transgenic nematodes (Levitan and Greenwald, 1995;Rahway, New Jersey 07065
Levitan et al., 1996), demonstrating that the two proteins
are functional homologs.
Recently, we and others produced mice deficient inSummary
PS1 and showed that mammalian PS1 may also function
in Notch signaling (Shen et al., 1997; Wong et al., 1997).Mutations in presenilin 1 (PS1) are linked to early onset
PS1 null mice die before or soon after birth with strikingof familial Alzheimer's disease (FAD) and are shown
vertebral skeletal malformations, CNS neuronal cell loss,to foster production of Ab1±42/43 in FAD patients and
and severe brain and/or spinal cord hemorrhage (Shentransgenic mice. PS1 null mice are embryonic lethal
et al., 1997; Wong et al., 1997). Neuronal cell loss andand exhibit axial skeleton malformation and CNS de-
hemorrhage phenotypes indicate that PS1 is requiredfects. We show that transgenic mouse lines express-
for CNS development.ing either the wild-type human PS1 protein or human
The functions of PS1 in development revealed by loss-PS1 with the A246E FAD mutation can rescue the PS1
of-function mutations in C. elegans and in the mouseknockout mouse from embryonic lethality to similar
may not be directly linked to the roles of PS1 mutationsdegrees, indicating that the mutation does not lead to
in AD. To understand the pathological mechanism ofloss ofPS1 function duringdevelopment. Furthermore,
PS1 FAD mutations, it is important to determine whethera 50% reduction of PS1 activity in PS11/2 mice does
they are gain- or loss-of-function mutations. More thannot lead to Ab1±42/43 increase, whereas expression
30 missense mutations and one in-frame splice site mu-of human mutant PS1 on murine PS1 null background
tation have been identified that are distributed through-is sufficient to elevate Ab1±42/43, supporting a gain-
out the PS1 protein (Perez-Tur et al., 1995; Cruts et al.,of-function activity as the result of the PS1 mutation.
1996). The facts that no nonsense or frameshift muta-
tions have been found in PS1 and that the mutationsIntroduction
enhance Ab1±42/43 production dominantly suggest that
these are gain-of-misfunction mutations. Contrary toAlzheimer' s disease (AD) is neuropathologically charac-
this interpretation, however, several human PS1 pro-terized by the deposition of extracellular b-amyloid (Ab)
teins containing FAD mutations appear to be substan-plaques, the accumulation of intracellular neurofibrillary
tially less effective than wild-type PS1 in rescuing sel-
tangles, and neuronal and synaptic loss. Approximately
12 deficiency in C. elegans (Levitan et al., 1996), making
10% of AD cases are familial and cosegregate with au-
it possible that these mutations may lead to a partial
tosomal dominant inheritance of mutations in genes,
loss of function. The dominant FAD phenotype could
including presenilin 1 (PS1) on chromosome 14 (Sher-
be due to haploid insufficiency or a dominant negative
rington et al., 1995), presenilin 2 (PS2) on chromosome
effect.
1 (Levy-Lahad et al., 1995; Rogaev et al., 1995), and
We report here that transgenes expressing either the
b-amyloid precursor protein (APP) on chromosome 21 wild-type human PS1 or the human PS1 containing the
(Chartier-Harlin et al., 1991; Goate et al., 1991; Mullan et
A246E FAD mutation, under the transcriptional control
al., 1992). Mutations in all three genes lead to increased
of the human Thy-1 promoter, can rescue the PS1
production of either total Ab or Ab1±42/43; the latter is
knockout mouse from embryonic lethality to similar de-
considered to be the critical molecule in plaque deposi- grees. Brain Ab measurements show that mice express-
tion (Jarrett and Lansbury, 1993; Jarrett et al., 1993; ing the mutant PS1 protein on the murine PS1 null back-
Iwatsubo et al., 1994; Selkoe, 1996). Mutations in PS1 ground produce a highly significant increase in the level
trigger the most aggressive onset of AD at ages 30±50, of Ab1±42/43, while reduction of PS1 activity in hetero-
accounting for z25% of all early-onset cases (Sherring- zygous PS1 knockout mouse does not lead to Ab1±42/
ton et al., 1995; Cruts et al., 1996). The relative increase 43 increase. These results are consistent with the gain-
in the Ab1±42/43 level has been observed in plasma and of function interpretation of the PS1 FAD mutations with
fibroblast cell cultures derived from PS1 FAD subjects regard to Ab1±42/43 production.
and in transgenic mice expressing human PS1 FAD pro-
teins (Borchelt et al., 1996; Duff et al., 1996; Lemere Results
et al., 1996; Scheuner et al., 1996; Citron et al., 1997),
providing compelling evidence that PS1 mutations alter Protection against PS1 Null Lethality by
APP processing and Ab1±42/43 production. Subcellular Wild-Type and Mutant Human PS1
PS1 localization inendoplasmic reticulum(ER) and Golgi Using a neuronal-specific human Thy-1 promoter (Gor-
complex suggests that it could indeed be involved in don et al., 1987), we established both wild-type (Thy-
PS1) and mutant (Thy-PS1A246E) human PS1 trans-
genic lines (Figure 1a). Measurement of PS1 levels in*To whom correspondence should be addressed.
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Figure 1. Thy-PS1 Transgene Expression
(a) Schematic representation of the wild-type
and mutant human PS1 transgene constructs.
The 1.4 kb wild-type PS1or PS1A246EcDNAs
were inserted between the human Thy-1 pro-
moter and SV40 small t intron and polyA se-
quences. The SV40 primer pair was used for
transgene genotyping.
(b) Immunoblot of protein lysates (60 mg/lane)
from brain (lanes 1±7) and embryonic head
(lanes 8±9) reacted with the PS1 loop anti-
body. In lanes 1 and 2, Thy-PS1 transgenic
lines 10±8 and 17±2 show about equal signal
intensity for hPS1 (upper band) and mPS1
(lower band). Lane 3 shows Thy-PS1 line 10±8
rescued mouse, expressing only hPS1. Lanes
4±6 show Thy-PS1A246E transgenic lines
16±3, 22±1, and 16±4, respectively, express-
ing both the hPS1 and mPS1. Lanes 4 and 5
show more hPS1 staining than native mPS1.
Lane 7 shows Thy-PS1A246E line 16±3 res-
cued mouse, expressing hPS1 only. Lanes 8
and 9 show day 18.5 embryonic protein ex-
tract from a heterozygous (1/2) and a homo-
zygous (2/2) PS1 knockout mouse, respec-
tively. At the bottom is a b-tubulin loading
control.
brain protein lysates by Western blotting, using an anti- producing only the human PS1 proteins (Figure 1b, lanes
3 and 7).loop PS1 antibody (Thinakaran et al., 1996), showed that
human PS1 C-terminal fragments accumulated in these Of the two Thy-PS1 lines tested (lines 10±8 and 17±2;
Table 1), both completely rescued the hemorrhage andlines ranging from about 0.53 to 1.53 that of the endog-
enous mouse PS1 (Figure 1b). other neuronal defects as well as embryonic lethality of
the PS1 null mouse, whereas the axial skeleton deformi-To determine whether human PS1 transgenes could
prevent lethality in the PS1 null mouse, we introduced ties were partially corrected. The rescued progenies,
heterozygous or homozygous for the transgene, werehuman Thy-PS1 and Thy-PS1A246E transgenes into the
murine PS1 null background (Wong et al., 1997) by viable and fertile. However, they were shorter in body
length and had short and kinky tails. Figure 2 showscrossing the human PS1 transgenic mice with heterozy-
gous PS1 knockout mice. F1 mice transgenic for the alcian blue± and alizarin red±stained skeleton prepara-
tions of newborn animals that are wild type (Figure 2a),human PS1 gene and heterozygous for the murine PS1
gene were identified and intercrossed in an attempt to PS1 null (Figure 2b), or PS1 null rescued by the wild-type
transgenic line 10±8 (Figure 2c). The vertebral column ofproduce F2 mice homozygous for the murine PS1 null
allele and positive for the human PS1. Genotyping a wild-type neonate normally possesses seven cervical
vertebrae and thirteen thoracic vertebrae that supportshowed that viable PS1 null transgene±positive pups
could be identified, demonstrating that the embryonic the same number of ribs (Figure 2a). In PS1 null newborn,
the number of cervical segments is reduced to four tolethality of the PS1 null mouse could be prevented by
either the wild-type or the mutant Thy-PS1 transgenes. six, with consistent absence of atlas (C-1 vertebra) and
frequent fusing of neighboring segments; the numberAs a result, we were able to establish transgenic lines
Table 1. Rescue of Murine PS1 Null Defects by Human PS1 Transgenes
Rescue Activitya mPS12/2; hPS1b
Transgene Lines Lethality Skeleton Hemorrhage Total Ratiob
Thy-PS1 10-8 111 11 111 12/80 2.4/16
17-2 111 11/111 111 4/39 1.6/16
Thy-PS1A246E 16-3 111 11/111 111 26/77 5.4/16
16-4 111 111 111 10/43 3.7/16
16-1 1 1/2 111 1/21 (5)c 0.8/16
22-1 2 1/2 111 0/29 (4)c 0/16
a Relative level of rescue; 2, none; 1, minimum; 11, partial; 111, complete. The rescue of skeleton defect is heterogeneous among individual
mice, and therefore ranges are listed.
b Number of rescued pups versus total from weaning age animals.
c Numbers in parentheses indicate rescued mice found dead after birth.
d Test cross is an intercross between mPS11/2; hPS11/2 double heterozygotes; therefore, the expected ratio for complete rescue is 3/16.
Rescue of PS1 Null Mouse by Human PS1
613
compressed. However, in contrast to thenormal number
of thirteen thoracic vertebrae, the rescued pup has only
eleven segments (Figure 2c). The lumbar-tail vertebrae
are largely disorganized and show delayed and unsym-
metrical ossification, resulting in a split vertebra and a
twisted tail. Slower ossification in the vertebral column
apparently contributed to their slower growth.
Four Thy-PS1A246E mutant transgenic lines (lines
16±1, 16±3, 16±4, and 22±1) were tested for rescue activ-
ity. Although all four lines were able to completely cor-
rect the hemorrhage and neuronal cell loss seen in PS1
null embryos, they yielded a dramatically different effi-
ciency in their ability to rescue the axial skeleton defects
as well as lethality (Table 1): lines 16±3 and 16±4 resulted
in a nearly complete rescue of the vertebral deformities,
and most of the rescued mice were indistinguishable
from their littermate controls. Figure 2d shows the bone
staining of a rescued neonate, heterozygous for the mu-
tant transgene from line 16±3. Compared to control (Fig-
ure 2a), the rescued pup has the correct number of
cervical and thoracic vertebrae and a normal level of
ossification. The structure looks almost completely nor-
mal except for a minor kink in the tail.
In contrast to lines 16±3 and 16±4, mutant line 22±1
rescued neonates showed little improvement in the axial
skeleton structure compared to PS1 null pups, and none
survived beyond birth (see below for transgene expres-
sion in this line). Line 16±1 resulted in partial rescue of
the lethality since only a low percentage of the rescued
mice (0.76/16 as compared to the expected 3/16) were
viable. The rest died soon after birth (Table 1). The hem-
orrhage-free but otherwise PS1 null±like newborns most
likely die of vertebral deformities. The differential correc-
tion of the CNS hemorrhaging and skeletal defects sug-
gests that these two pathologies are not causally re-
lated. Since the expected numbers of rescued pups
were recovered at birth (4.6/16 and 2.2/16 for lines 16±1
and 22±1, respectively, versus the expected 3/16), ex-
pression of the human transgene in these lines pre-
vented the prenatal lethality of the PS1 null mice.
Hematoxylin and eosin (H&E) staining of sagittal sec-
Figure 2. Newborn Skeletal Preparations Stained with Alcian Blue
tions of E15.5 embryos (data not shown) confirmed thatand Alizarin Red
in both the wild-type and mutant human PS1 rescuedCompared with wild-type (a) andnull (b)samples, theThy-PS1A246E
mice, the defects seen in the anterior region of the nullrescued mouse (d) showed almost complete correction of vertebrate
embryos were completely corrected. Minor defectsdefects except for a minor kink in the tail. It has the normal number
of 7 cervical and 13 thoracic vertebrae, as seen in the wild-type could still be seen in posterior vertebrates. CNS hemor-
control (a), in contrast to the varying 4±6 cervical and 9±10 thoracic rhaging could not be detected in spinal cord, brain pa-
segments found in knockout mice (b). The ossification centers are renchyma, ventricles, or other structures. Peri-ventricu-
well developed and properly organized, as in the wild-type skeleton.
lar neuronal lesions, as those reported by Shen et al.The Thy-PS1 line 10±8 rescued mouse (c) showed improvement in
(1997), were not observed in the rescued mice (data notcervical and thoracic regions over the knockout mouse(b) but exhib-
shown).its missing ribs, and its lumbar-tail segments are disorganized and
show delayed and unsymmetric ossification, resulting in a split ver-
tebra and a twisted tail.
Human PS1 Transgene Expression
The human Thy-1 promoter is predominantly active in
brain and less so in kidney, endothelial cells of bloodof thoracic segments and ribs is reduced to nine or ten,
again frequently fused (Figure 2b). The rescued neonate vessels, and connective tissues, and its expression in
other peripheral tissues is negligible (Gordon et al.,is larger than the null pup and shows vast improvement
in cervical and thoracic vertebrae compared to the 1987). Northern blot (data not shown) and Western blot
analysis (Figure 1b) showed that human PS1 is ex-knockout mouse (cf. Figures 2b and 2c). A complete set
of seven cervical vertebrae is restored. The thoracic pressed at levels comparable to those of the endoge-
nous murine PS1 in the brains of transgenic mice. Invertebrae and ribs display degrees of ossification similar
to those of the wild-type skeleton and are no longer situ hybridization showed that the human PS1 mRNA
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Figure 3. Embryonic and Adult Brain Expres-
sion of the Human PS1 Transgenes by In Situ
Hybridization
(a) Moderate expressions in E13.5 embryos
are detected along the vertebral and spinal
column in wild-type lines 10±8 and 17±2 and
in mutant lines 16±4 and 16±1. Higher signal
is found in mutant line 16±3. Hybridization
signal in mutant line 22±1 is similar to the
nontransgenic control (WT).
(b±e) Four coronal sections of adult brain(mu-
tant line 16±3) cut from front to back, respec-
tively. Transgenic PS1 expression can be de-
tected in various brain regions but most
significantly in cortex, hippocampus, and cer-
ebellum. In each panel, the image shown on
the left represents the signal by hybridization
with the antisense oligo probe, and the image
shown onthe right is hybridization of adjacent
sections with 100-fold excess of cold oligo,
representing nonspecific signal.
was widely expressed and is mostly abundant in hippo- of development but was not sufficient for most embryos.
Expression in mutant line 22±1 (Figure 3a) was at thecampus, cortex, and cerebellum (Figures 3b±3e). How-
ever, the levels of human PS1 expression in adult brain nontransgenic control level, accounting for the lack of
rescue by this line. Since the mutant line 16±4 had ex-of the different transgenic lines are not indicative of their
ability to rescue the embryonic lethality of the PS1 null pression comparable to that of the wild-type lines 10±8
and 17±2 but gave more complete rescue than the twomice (compare lines 16±3, 16±4, and 22±1; Table 1; Fig-
ure 1b). We therefore examined embryonic transgene wild-type lines, and since the failure of mutant line 22±1
to rescue lethality was due to lack of embryonic expres-expression by in situ hybridization at E9.5, E13.5, and
E18.5 of development. sion, the in situ results support the conclusion that the
PS1A246E protein did not lose PS1 functions requiredWhen examined by whole-mount in situ hybridization,
weak and ubiquitous expression of Thy-PS1 transgenes for development. At E18.5, transgene expression be-
came more restricted to the CNS with weak staining incould be detected above background in E9.5 embryos.
However, the signal was too low to be quantitatively kidney (data not shown).
compared (data not shown). In situ hybridization of mid-
saggital sections of E13.5 embryos revealed that in wild- Brain Ab Levels in Transgenic Mice
Rescue of PS1 null lethality in mice by the human PS1type lines 10±8 and 17±2 and in mutant lines 16±4 and
16±1 (Figure 3a), the transgeneswere expressed at mod- transgenes allows the analysis of Ab levels in brains of
the humanized PS1 mice, in which the only PS1 availableerate levels along vertebra-spinal column, areas se-
verely affected in PS1 null embryos. Expression in other is of human origin. Mouse Ab40 and Ab1±42/43 levels
were measured by quantitative sandwich ELISA assaystissues was lower. The mutant line 16±3 (Figure 3a) gave
similar expression patterns but the signal was stronger. (Gravina et al., 1995; Duff et al., 1996) in brain lysates
of the knockout mice (3 months of age) rescued by Thy-That line 16±3 expression was higher than line 16±4 but
appears to have slightly lower rescue activity indicates PS1 (line 10±8) and Thy-PS1A246E (lines 16±3 and 16±4)
transgenes and of nontransgenic wild-type (PS11/1) andthat the E13.5 expression revealed by in situ hybridiza-
tion is not an absolute measure of the rescuing ability. heterozygous knockout (PS11/2) mice. Brain transgene
expression in lines 10±8 and 16±4 were comparable,Subtle variations of transgene expression in time and
space would influence rescue outcome. The rescue ac- while that in line 16±3was higher (Figure 1b). Two signifi-
cant observations emerged from this measurement (Fig-tivity of the mutant line 16±1 appeared to be affected
by such variation. The low-to-moderate expression seen ure 4). First, mice heterozygous for the murine PS1
(mPS11/2) produce lower instead of higher levels of bothin line 16±1 could, on rare occasions, enable completion
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decrease in the humanized mice is that human PS1
stimulates a higher fraction of Ab1±42/43 production as
compared to mouse PS1.
Discussion
Functional Rescue of PS1 Null Lethality
by Human PS1 Transgenes
We show that the human PS1 protein can substitute
for mouse PS1 during development, confirming a high
degree of functional conservation between the two pro-
teins and allowing generation of humanized PS1 trans-
genic mice. The rescue of the PS12/2 lethality by the
A246E mutant protein indicates that thehuman PS1 FAD
mutation does not compromise normal PS1 activity. A
low level of expression of either wild-type or mutant
A246E human PS1 during embryogenesis is sufficient
to support normal PS1 function during development.
Interestingly, although the Thy-PS1A246E transgenic
lines 16±1 and 22±1 are unable to effectively rescue the
axial skeleton defects and the lethality of the PS1 null
mice, the neuronal lesion and CNS hemorrhaging are
completely corrected, indicating a normal PS1 CNS ac-
tivity of the mutant protein expressed at sub-optimal
levels.
Although both the wild-type and mutant PS1 trans-
genes can complement the mouse PS1 null mutation,Figure 4. PS1A246E Elevates Brain Ab1±42/43 in the Absence of
variations were observed in the degree of rescue amongEndogenous Mouse PS1
different lines. This indicates that the levels of transgeneThe brain Ab1±42/43 6 SEM and Ab40 6 SEM values are graphically
expression were close to a threshold, presumably thepresented in the upper and lower panels, respectively (note that the
scales differ). Mouse genotypes and sample sizes are given below minimal activity required for normal development. Pertur-
the graph. Abbreviations: wt, wild-type; mt, mutant. Asterisks (*) bation of the temporal and spatial expression patterns
indicate values that differ statistically (t test) from the level in the of the transgenes due to the chromosomal integration
mPS11/1 control (column 1).
site, as partly shown by the E13.5 in situ hybridization*Ab1±42/43: (2) p , 0.001, (4) p , 0.001, and (5) p , 0.001. Ab40:
(Figure 3a), is most likely the cause of the fluctuations(2) p , 0.05, (3) p , 0.05, (4) p , 0.05, and (5) p , 0.01. Note that
in the rescue outcome. The threshold expression by theboth the Ab40 and Ab1±42/43 levels in the mPS11/2 animals (column
2) are lower than the mPS11/1 control levels (column 1) and that the Thy-PS1 transgenes allows valid comparison between
Ab40 levels in either the wild-type or the mutant transgene rescued the wild-type and mutant PS1 proteins in their rescue
mice (columns 3, 4, and 5) are also lower than the control level activities.
(column 1).
Assessment of activities of PS1 mutants in C. elegans
yielded somewhat different results. In the study by Levi-
Ab40 or Ab1±42/43 than wild-type controls. This finding tan et al. (1996), several PS1 FAD mutants, including
indicates that the effect of PS1 FAD mutations on PS1A246E, were found to be substantially less active
Ab1±42/43 production is not due to a loss of PS1 func- than the wild-type protein in compensating for sel-12
tion. Second, dramatic increases in Ab1±42/43 level are deficiency. This discrepancy in rescue between C. ele-
seen in the mPS12/2;Thy-PS1A246E genotype, as com- gans and mouse might be attributable to differences in
pared with the wild-type Thy-PS1 rescued mice or non- the nature of the defects. For example, unlike the murine
transgenic controls (Figure 4, upper panel). This result PS1 null mutation, the C. elegans sel-12 mutant is most
is consistent with the increases in Ab1±42/43 observed likely not a complete loss-of-function mutant, and the
from PS1 FAD patients and transgenic mice expressing murine somitogenic and C. elegans egg chamber differ-
mutant PS1 protein (Borchelt et al., 1996; Duff et al., entiation pathways may respond differently to PS1 pro-
1996; Scheuner et al., 1996; Citron et al.,1997; this study; tein expression; in addition, variability in episomal trans-
data not shown). Since the only PS1 present in the lines gene expression in the C. elegans rescue study was not
16±3 and 16±4 rescued mice is the mutant PS1, the evaluated.
Ab1±42/43 elevation can be attributed to the FAD mu-
tation.
We noticed that a reduction or removal of endogenous PS1 and Ab Production
Observations of elevation in the level of Ab1±42/43 ormurine wild-type PS1 leads to a mild decrease in the
steady-state level of Ab40, since it is significantly lower the ratio of Ab1±42/43:Ab40 in fibroblast and plasma
samples of PS1 FAD patients, in PS1 FAD cell lines, andin mPS11/2 mice and in mPS12/2 mice rescued by either
the human Thy-PS1 or Thy-PS1A246E transgenes (Fig- in transgenic mice (Borchelt et al., 1996; Duff et al.,
1996; Scheuner et al., 1996; Citron et al., 1997) stronglyure 4, lower panel). A possible interpretation for theAb40
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numbers and homozygous individuals were determined by quantita-suggest that the pathogenic mechanism of the PS1 mu-
tive Southern analysis. Transgene identities in wild-type and mutanttations in AD involves an increase in Ab1±42/43 produc-
lines were verified by PCR typing, utilizing a DdeI restriction enzymetion. Previously published findings regarding the PS1
site created by the A246E mutation in the mutant transgene (data
FAD effect on Ab1±42/43 overproduction, and on the not shown). As in published results (Borchelt et al., 1996; Duff et
increase of the Ab1±42/43:Ab40 ratio, were all obtained al., 1996; Citron et al., 1997), no overt abnormalities were observed
in either the wild-type or the mutant human PS1 transgenic mice.in the presence of the wild-type PS1 alleles. Therefore,
it was difficult to distinguish whether the mutant effect
Western Blot Analysison Ab1±42/43 production results from (1) a gain of activi-
Protein lysates from transgenic brains or embryos were preparedties by the PS1 FAD proteins in Ab1±42/43 production,
(Thinakaran et al., 1996), separated (60 mg/lane) on 14% SDS-PAGE,(2) a partial loss of PS1 function, leading to increased
and transferred onto Nitrocellulose membrane (Hybond-ECL, Amer-
Ab1±42/43 production, or (3) a dominant negative inacti- sham). The blot was incubated with anti-loop PS1 antiserum (Thina-
vation of the wild-type PS1 by PS1 FAD proteins, which karan et al., 1996) followed by reacting with horseradish peroxidase
in essence argues that Ab1±42/43 overproduction is the (HRP) conjugated secondary antibody. The signal was detected
using the Amersham ECL system. The affinity of the anti-loop PS1result of loss of PS1 function. Our studies show that
antibody to human PS1 is about twice its affinity to mouse PS1mutant but not wild-type PS1 transgenic lines, in the
(S. Sisodia, personal communication).absence of the endogenous wild-type PS1, produce a
higher level of Ab1±42/43 than the wild-type controls,
Production of Rescued Mice and Skeletal Stainingindicating that the Ab1±42/43-enhancing effect is the
Human PS1 transgenic mice were mated with heterozygous PS1
intrinsic property of the mutant protein. This result, to- knockout mice (mPS11/2; Wong et al., 1997). Double heterozygous
gether with the observations that (1) PS1A246E is func- F1s were selected by PCR typing and intercrossed to produce prog-
tional in developing CNS and other tissues, (2) a 50% enies that are homozygous for the knockout allele in combination
with one or two copies of thetransgenes. All mice used in phenotypicreduction in wild-type murine PS1 expression in hetero-
and Ab analysis were of F2 generation and consist of 50% C57B6,zygous PS1 knockout mice does not lead to an increase
25% SJL, and 25% 129Sv.in Ab1±42/43 production, and (3) no nonsense or frame-
A set of three primers was used for genotyping of wild-type and
shift mutations have been identified in PS1 FAD cases, targeted PS1 alleles: (1) 59-AGCCAAGAACGGCAGCAGCAGCAT
supports the hypothesis that the mutation in PS1 FAD GACAGGCAGAG-39, (2) 59-CTTCCATGAGCCATTTGCTAAGTGC-39,
results in a gain of activities in Ab1±42/43 production. and (3) 59-CCATTGCTCAGCGGTGCTGTCCAT-39. Primer pairs (1)
and (2) amplify a 500 bp fragment from the endogenous PS1 allele.Recent analysis of neuronal cell cultures derived from
Primer (3) anneals to the neo sequence in the knockout constructPS1 null embryos revealed that Ab production was re-
and, when paired with primer (2), amplifies a 370 bp fragment ofduced by 80% in the absence of PS1 (De Strooper et
the knockout allele. The trimer set generates a single band of 500
al., 1998), suggesting that PS1 activity is required for the bp from wild-type (1/1), two bands of 500 bp and 370 bp from
amyloidogenic processing of APP. The mild decrease in heterozygous (1/2), and a single band of 370 bp from knockout
both Ab40 and Ab1±42/43 in mPS11/2 mice from the (2/2) mouse PS1 alleles.
Newborn skeletal samples were prepared by alcian and alizarinwild-type mPS11/1 levels (Figure 4) is in line with the
staining (Kimmel and Trammell, 1981).results of De Strooper et al. (1998), indicating that this
activity may be dose dependent. Observations of direct
In Situ Hybridizationphysical interaction between APP and PS1 by coimmu-
Whole mount in situ hybridization was performed as described (Wil-
noprecipitation are consistent with the Ab data and kinson, 1992) using an SV40 antisense riboprobe.
suggest that PS1 may serve as an auxiliary factor for For section in situ hybridization, 14 mm mid-sagittal sections of
g-secretase cleavage, assisting APP folding or mem- E13.5 and E18.5 embryos and adult brain sections (hPS11/2) were
thaw mounted on baked superfrost plus microslides and hybridizedbrane anchoring (Xia et al., 1997). Analysis of PS1 inter-
with a transgene-specific SV40 oligo probe, 59-CACACCACAGAAGTaction with APP and other proteins may lead to identifi-
AAGGTTCCTTCACAAAGATCCGGGACCAA AG-39, by the methodcation of the crucial biochemical pathways and secretases
of Sirinathsinghji and Dunnett (1993). The probe was labeled to 2 3responsible for Ab production.
106 cpm/ng DNA by [33P]dATP with terminal transferase (Boehringer-
Mannheim) and purified over a Sephadex G-50 spin column. Follow-
ing hybridization, the sections were exposed to Kodak Biomax film
Experimental Procedures
for 3 weeks.
Transgene Construction and Generation
Ab Measurementof Transgenic Mice
Hemibrains from transgenic mice were taken and homogenized inThe human wild-type PS1 and human PS1A246E transgenes under
70% formic acid. Homogenates were centrifuged at 100,000 3 gthe control of human Thy-1 promoter were generated by ligating a
for 1 hr. The supernatant was recovered and neutralized, and mouse1.4 kb KpnI-BamHI fragment containing PS1 (or PS1A246E) cDNA
Ab40 and Ab1±42/43 levels were analyzed using the BNT77/BA27sequence with a KpnI-BglII±cleaved pHZ024 vector, which contains
and BNT77/BC05 quantitative sandwich ELISA systems, as de-the human Thy-1 promoter (Van Rijs et al., 1985), a polylinker, and
scribed by Gravina et al. (1995) and Duff et al. (1996). Ab values ofSV40 small t intron and polyA sequences. A 5.8 kb Eco RI-XbaI
line 16±3 rescued mice were assayed in all experiments and werefragment containing human Thy-1 promoter, PS1 (or PS1A246E)
used to normalize the Ab levels of line 16±4, which were obtainedcDNA, and SV40 sequence was excised from the plasmid, gel puri-
at a later time than the rest of the data shown but in parallel withfied, and injected into the pronuclei of B6SJL embryos as described
line 16±3.by Hogan et al. (1986). Transgenic founders were identified by PCR
with a SV40 primer pair (Reneker et al., 1995)ÐSV-sense, 59-GTGAA
GGAACCTTACTTCTGTGGTG-39, and SV-antisense, 59-GTCCTTGG Acknowledgments
GGTCTTCTACCTTTCTC-39Ðand were bred with B6SJL/F1 mice to
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